GLUCOSE 50 % BAXTER

Quốc gia: Israel

Ngôn ngữ: Tiếng Anh

Nguồn: Ministry of Health

Thành phần hoạt chất:

GLUCOSE AS MONOHYDRATE

Sẵn có từ:

BAXTER HEALTHCARE DISTRIBUTION LTD., ISRAEL

Mã ATC:

B05CX01

Dạng dược phẩm:

SOLUTION FOR INFUSION

Thành phần:

GLUCOSE AS MONOHYDRATE 500 G / 1 L

Tuyến hành chính:

I.V

Loại thuốc theo toa:

Required

Sản xuất bởi:

BAXTER HEALTHCARE LTD. U.K.

Khu trị liệu:

GLUCOSE

Chỉ dẫn điều trị:

High caloric carbohydrate infusion, hypoglycaemia

Ngày ủy quyền:

2023-01-29

Đặc tính sản phẩm

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Glucose 50% Baxter
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
100 mL concentrate for solution for infusion
Contain Glucose monohydrate
55.0 g
(Equivalent to 50.0 g anhydrous glucose)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Concentrate for solution for infusion
Clear, colourless or not more than faintly yellow solution.
Energy: 835 kJ/100 mL
≙
200 kcal/100 mL
Theoretical osmolarity:
2,770 mOsm/L
Titratable acidity (pH 7.4): < 1.5 mmol/L
pH:
3.2-5.5
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
High caloric carbohydrate infusion, Hypoglycemia.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
DOSAGE
Adults:
The dosage depends on age, weight and clinical condition of the
patient. Up to 14 ml/kg body weight/day.
Flow rate:
Up to 1.0 ml/kg bw/h or (for 70 kg patient) up to 23 drops/min = 70
ml/h.
For patients in a markedly depleted nutritional state, the above
drop/flow rates have to be
reduced ac cordingly.
Insulin induced hypoglycemia:
Determine blood glucose before injecting dextrose.
Children:
According to individual requirements.
ROUTE OF ADMINISTRATION
I.V. via a central venous catheter.
For total parenteral nutrition Glucose Injection is administered by
slow intravenous infusion
(a) after admixture with amino acid solutions via an indwelling
catheter with the tip positioned
in a large cen- tral vein, preferably the superior vena cava, or (b)
after dilution with sterile
water for injection. Dosage should be adjusted to meet individual
patient requirements.
4.3
CONTRAINDICATIONS
●
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
●
Hyperglycaemia
●
Hypokalaemia
●
Acidosis
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Glucose 50% Baxter is a hypertonic solution. In the body, however,
glucose-containing
fluids can become extremely hypotonic due to rapid glucose
metabolisation.
Depending on the tonicity of the solution, the volume and the rate of
infusion and dependin